Pharmacogenomics Market Revenue 2025 to 2034
Pharmacogenomics Market Revenue 2025 to 2034
Pharmacogenomics Market (By Technology: DNA Sequencing, Microarray, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry; By Applications: Drug Discovery, Pain Management, Neurology, Oncology, Cardiovascular Diseases, Infectious Diseases, Psychiatry, Others; By End User: Hospitals, Clinics, Research Institutes, Medical & Academic Institutes; By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy; By Region: North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 19.59 Bn
Forecast Year, 2034
USD 43.09 Bn
CAGR, 2025 - 2034
9.17%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The pharmacogenomics market, valued at USD 19.59 billion in 2025, is projected to reach USD 43.09 billion by 2034, growing at a robust CAGR of 9.17%. This growth is driven by advancements in personalized medicine, enabling tailored drug therapies for improved patient outcomes.
Pharmacogenomics Market Size Analysis
Pharmacogenomics Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| DNA Sequencing | 5.88 | 6.42 | 7.00 | 7.65 | 8.35 | 9.11 | 9.95 | 10.86 | 11.86 | 12.94 |
| Microarray | 4.90 | 5.35 | 5.84 | 6.37 | 6.96 | 7.59 | 8.29 | 9.05 | 9.88 | 10.79 |
| Polymerase Chain Reaction | 2.94 | 3.21 | 3.50 | 3.82 | 4.17 | 4.56 | 4.97 | 5.43 | 5.93 | 6.47 |
| Electrophoresis | 1.96 | 2.14 | 2.33 | 2.55 | 2.78 | 3.04 | 3.32 | 3.62 | 3.95 | 4.31 |
| Mass Spectrometry | 3.92 | 4.28 | 4.67 | 5.10 | 5.57 | 6.08 | 6.63 | 7.24 | 7.90 | 8.63 |
Pharmacogenomics Market Size By Applications 2025 to 2034 (USD Billion)
| Applications | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery | 5.88 | 6.42 | 7.00 | 7.65 | 8.35 | 9.11 | 9.95 | 10.86 | 11.86 | 12.94 |
| Pain management | 2.94 | 3.21 | 3.50 | 3.82 | 4.17 | 4.56 | 4.97 | 5.43 | 5.93 | 6.47 |
| Neurology | 1.96 | 2.14 | 2.33 | 2.55 | 2.78 | 3.04 | 3.32 | 3.62 | 3.95 | 4.31 |
| Oncology | 2.94 | 3.21 | 3.50 | 3.82 | 4.17 | 4.56 | 4.97 | 5.43 | 5.93 | 6.47 |
| Cardiovascular diseases | 1.96 | 2.14 | 2.33 | 2.55 | 2.78 | 3.04 | 3.32 | 3.62 | 3.95 | 4.31 |
| Infectious diseases | 1.96 | 2.14 | 2.33 | 2.55 | 2.78 | 3.04 | 3.32 | 3.62 | 3.95 | 4.31 |
| Psychiatry | 0.98 | 1.07 | 1.17 | 1.27 | 1.39 | 1.52 | 1.66 | 1.81 | 1.98 | 2.16 |
| Others | 0.98 | 1.07 | 1.17 | 1.27 | 1.39 | 1.52 | 1.66 | 1.81 | 1.98 | 2.16 |
Pharmacogenomics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 7.84 | 8.55 | 9.34 | 10.20 | 11.13 | 12.15 | 13.27 | 14.48 | 15.81 | 17.26 |
| Asia Pacific | 4.90 | 5.35 | 5.84 | 6.37 | 6.96 | 7.59 | 8.29 | 9.05 | 9.88 | 10.79 |
| Europe | 3.92 | 4.28 | 4.67 | 5.10 | 5.57 | 6.08 | 6.63 | 7.24 | 7.90 | 8.63 |
| LAMEA | 2.94 | 3.21 | 3.50 | 3.82 | 4.17 | 4.56 | 4.97 | 5.43 | 5.93 | 6.47 |
Pharmacogenomics Market Size to Lead USD 43.09 Billion by 2034
The pharmacogenomics market size was evaluated at USD 19.59 billion in 2025 and is expected to grow around USD 43.09 billion by 2034 a CAGR of 9.17%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
